Track & Trace RFID pour les fondus du futur (pas si lointain)

[OXYGEN]

“According to William K Hubbard, Associate Commissioner for Policy and Planning, FDA, pharmaceutical companies are expecting RFID technology to become the standard for providing track-and-trace protection for drugs in the future... Pfizer has announced its plans to put RFID tags on all bottles of Viagra to prevent counterfeit drugs from being used... Purdue Pharma also announced that it will be tagging bottles of OxyContin to authenticate and track-and-trace the pain medication.”

Et en la matière...the Ultimate is:
« Smart Dust –- tiny RFID devices with built-in sensors powered, for example, by micro nuclear energy sources capable of:

• Communicating with one another and transmitting to distributed base station databases and business intelligence systems their identity, health, position and sensor measurements—and decisions.
• Utilizing their own sensors as well as information from the collective smart-dust network databases and knowledge resources to adapt their role and update their parameters.”


http://www.commercemonde.com/commercemonde.php?niveau=2&id=48

[splendid2428]

Article pour article, je vais une fois demander à Nicolas de faire un petit cours sur les clefs qu'il doit mettre pour refaire le site de son école ( cela sera sûrement compris par tout le monde)

[OXYGEN]

La RFID s’invite dans les laboratoires de recherche médicale
Jeudi 30 juin 2005


Quatre des plus prestigieux laboratoires publics français de recherche biologique ont décidé d’utiliser des systèmes RFID d’identification et traçabilité : l’Institut Paoli Calmettes (centre régional anti-cancéreux), l’Hôpital de la Timone, l’Hôpital de la Conception et l’Hôpital Nord. L’étiquette ARIO SDM de Tagsys fonctionne à la fréquence de 13,56 MHz et permet un suivi et une gestion fiables, précis et sécurisés des échantillons biologiques en bio banques.

suite à http://www.itrmanager.com/41750-rfid,invite,laboratoires,recherche,medicale.html

[OXYGEN]

There also has been great progress towards development and implementation of a standard electronic track-and-trace system, in particular using radio-frequency identification (RFID) for widespread use in the drug distribution system. Significant advances are also being made in developing an electronic pedigree (chain of custody) for drugs,
The pharmaceutical industry is contributing to this effort by increasing its use of anti-counterfeiting technologies such as holograms, colour shifting inks and covert markings on products and packaging, in addition to starting pilot studies on RFID.

(...)

The DNA-DMID will be a contactless nano-technology with a reader capable of identifying a unique magnetic signature embedded into labels, tags and products. The reader has the ability to read directly through the walls of cartons and containers and identify the contents inside.

The MicroWire products emanate magnetic signatures, enabling identification by hand-held or production line contactless readers. The DNA-embedded MicroWires can be integrated into product packaging, cartons, paper, tags, clothing, passports, security documents, works of art and virtually any product requiring identification.


http://www.in-pharmatechnologist.com/news/news-ng.asp?n=61080-supply-chain-deal